文献速递主动脉疾病

腹主动脉瘤腔内修复术患者术前基于全身炎症的评分系统的预后价值

The prognostic value of preoperative systemic inflammation-based scoring in patients undergoing endovascular repair of abdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2023-04-20

本研究回顾性纳入三个三级血管中心5年间连续接受择期标准或复杂腔内动脉瘤修复术的506例腹主动脉瘤患者,评估基于中性粒细胞与淋巴细胞比值和改良格拉斯哥预后评分构建的全身炎症分级与生存的关系。中位随访68.0个月,死亡163例;全身炎症分级与生存相关,多因素分析中年龄和全身炎症分级保留独立关联,全身炎症分级可预测1年死亡率。

要点

  • 全身炎症分级与腹主动脉瘤腔内修复术后生存相关,多因素分析风险比1.20。
  • 全身炎症分级预测1年死亡率曲线下面积0.68。
  • 作者认为该评分可用于识别术后不良结局高风险患者,但需进一步前瞻性研究。

核心结论

  • 全身炎症反应标志物如全身炎症分级可用于识别接受标准或复杂腔内修复术的腹主动脉瘤患者中不良结局风险较高者。
  • 这些发现需在大型前瞻性队列研究中进一步验证。

研究设计与样本

  • 回顾性研究,从三个三级血管中心连续识别5年间接受择期标准腔内动脉瘤修复术和开窗/分支腔内动脉瘤修复术的患者。
  • 最终纳入506例患者,中位随访68.0个月(四分位距27.3个月),随访期间死亡163例。

主要发现

  • 全身炎症分级0级、1级、2级、3级、4级亚组的平均生存期分别为80.7个月(95%CI 76.5-85.0)、78.7个月(95%CI 72.7-84.7)、61.0个月(95%CI 51.1-70.8)、65.1个月(95%CI 45.0-85.2)、54.9个月(95%CI 34.4-75.3)(P < .05)。
  • 全队列单因素分析中,年龄(P < .001)、体重指数(P < .05)、高肌酐(P < .05)和全身炎症分级(P < .05)与生存相关。
  • 多因素分析中,年龄(风险比1.72;95%CI 1.29-2.31;P < .001)和全身炎症分级(风险比1.20;95%CI 1.02-1.40;P < .05)保留独立关联。
  • 全身炎症分级升高预测1年死亡率(曲线下面积0.68;95%CI 0.58-0.78;P < .01)。

关键数值与推荐

  • 全身炎症分级由术前中性粒细胞与淋巴细胞比值和改良格拉斯哥预后评分计算并组合而成。
  • 主要结局为随访期间全因死亡率,比较不同全身炎症分级亚组。

临床怎么用

  • 作者认为全身炎症分级可用于识别接受标准或复杂腔内修复术的腹主动脉瘤患者中不良结局风险较高者。
  • 原文未据此给出具体临床推荐。

局限性

  • 原文结论指出这些发现需在大型前瞻性队列研究中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Abdominal aortic aneurysm (AAA) is a common condition that is predominantly managed in the United Kingdom by endovascular aneurysm repair (EVAR). Activation of the systemic inflammatory response (SIR) appears to offer prognostic value in patients with vascular disease. The present study examines the relationship between the SIR and survival in patients undergoing standard and complex endovascular aneurysm repair (EVAR and fenestrated/branched [F/B]-EVAR). METHODS: Consecutive patients undergoing elective EVAR and F/B-EVAR were retrospectively identified from three tertiary vascular centers over a 5-year period. Neutrophil:lymphocyte ratio and modified Glasgow Prognostic Score were calculated from preoperative blood results and combined into the systemic inflammatory grade (SIG). The primary outcome was all-cause mortality during the follow-up period, which was compared between subgroups of SIGs. RESULTS: There were 506 patients included in the final study, with a median follow-up of 68.0 months (interquartile range, 27.3 months), and there were 163 deaths during the follow-up period. Mean survival in the SIG 0 vs SIG 1 vs SIG 2 vs SIG 3 vs SIG 4 subgroups was 80.7 months (95% confidence interval [CI], 76.5-85.0 months) vs 78.7 months (95% CI, 72.7-84.7 months) vs 61.0 months (95% CI, 51.1-70.8 months) vs 65.1 months (95% CI, 45.0-85.2 months) vs 54.9 months (95% CI, 34.4-75.3 months) (P < .05). In the entire cohort, age (P < .001), body mass index (P < .05), high creatinine (P < .05), and SIG (P < .05) were associated with survival on univariate analysis, with retained independent association for age (hazard ratio, 1.72; 95% CI, 1.29-2.31; P < .001) and SIG (hazard ratio, 1.20; 95% CI, 1.02-1.40; P < .05) on multivariate analysis. Increasing SIG (area under the curve, 0.68; 95% CI, 0.58-0.78; P < .01) predicted 1-year mortality. CONCLUSIONS: Markers of the SIR such the SIG may be used to identify patients at higher risk of adverse outcome in patients undergoing EVAR and F/B-EVAR for abdominal aortic aneurysms. These findings warrant further investigation in large prospective cohort studies.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bradley NA, Walter A, Wilson A, et al. The prognostic value of preoperative systemic inflammation-based scoring in patients undergoing endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 2023. PMID: 37086821. doi:10.1016/j.jvs.2023.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。